ICE guidance on sotagliflozin for type 1 diabetes

被引：4

作者：

Adler, Amanda I. ^{[1
,2
,3
]}

Cronshaw, Jessica ^{[3
]}

Prescott, Carl ^{[3
]}

Patel, Sanjeev ^{[4
]}

Donegan, Eleanor ^{[3
]}

Hayre, Jasdeep ^{[3
]}

机构：

[1] Oxford Ctr Diabet & Endocrinol, Diabetes Trials Unit, Oxford, England

[2] NIHR Oxford BRC, Oxford, England

[3] Natl Inst Hlth & Care Excellence, Manchester, Lancs, England

[4] Kings Coll Hosp London, London, England

来源：

LANCET DIABETES & ENDOCRINOLOGY | 2020年 / 8卷 / 04期

关键词：

INTERVENTIONS; OUTCOMES; MODEL;

D O I：

10.1016/S2213-8587(20)30066-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：274 / 275

页数：2

共 10 条

[1]

[Anonymous], NICE TECHN APPR GUID

[2] A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) [J].

Clarke, PM ;

Gray, AM ;

Briggs, A ;

Farmer, AJ ;

Fenn, P ;

Stevens, RJ ;

Matthews, DR ;

Stratton, IM ;

Holman, RR .

DIABETOLOGIA, 2004, 47 (10) :1747-1759

[3]

Danne T, 2018, DIABETES CARE, V41, P1981

[4] The Risk of Acute Pancreatitis After Initiation of Dipeptidyl Peptidase 4 Inhibitors: Testing a Hypothesis of Subgroup Differences in Older US Adults [J].

Hong, Jin-Liern ;

Buse, John B. ;

Funk, Michele Jonsson ;

Pate, Virginia ;

Sturmer, Til .

DIABETES CARE, 2018, 41 (06) :1196-1203

[5] Validation of the IMS CORE Diabetes Model [J].

McEwan, Phil ;

Foos, Volker ;

Palmer, James L. ;

Lamotte, Mark ;

Lloyd, Adam ;

Grant, David .

VALUE IN HEALTH, 2014, 17 (06) :714-724

[6] Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions [J].

Nathan, David M. ;

Bayless, Margaret ;

Cleary, Patricia ;

Genuth, Saul ;

Gubitosi-Klug, Rose ;

Lachin, John M. ;

Lorenzi, Gayle ;

Zinman, Bernard .

DIABETES, 2013, 62 (12) :3976-3986

[7]

NICE, 2019, NICE TECHN APPR GUID

[8]

NICE, 2015, NICE GUID NG17 TYP 1

[9]

NICE, 2011, NICE QUAL STAND QS6

[10] The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making [J].

Palmer, AJ ;

Roze, S ;

Valentine, WJ ;

Minshall, ME ;

Foos, V ;

Lurati, FM ;

Lammert, M ;

Spinas, GA .

CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 :S5-S26

← 1 →